Institution statistics

INSERM - TRANSFERT SA - France 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:700-800
Networking Rank (Reputation):500-600
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:600-700
2014
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:64
Partner Constancy:42
Project Leadership Index:61
Diversity Index:39
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:64
Networking Rank (Reputation):500-600
Networking Rank (Reputation):500-600
Partner Constancy:40
Project Leadership Index:69
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:600-700
Networking Rank (Reputation):800-900
Partner Constancy:300-400
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):500-600
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:800-900
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 98
As coordinator: 2
As participant: 96
Sole participant: 0
Coordinator / Participant Ratio: 0.02*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 59.655.082 2.303.138 7
2019 0 80.841.950 2.016.719 7
2018 0 14.344.078 749.250 2
2017 0 5.979.607 351.875 1
2016 0 41.731.414 1.107.237 4
2015 0 21.630.050 1.514.491 4
2014 0 15.674.149 792.234 2
2013 5.900.720 59.723.277 3.843.620 1 9
2012 1.999.985 41.700.816 3.575.538 1 7
2011 0 25.245.825 1.669.330 5
2010 0 43.611.847 3.145.212 9
2009 0 20.167.421 1.757.007 4
2008 0 28.204.007 2.881.525 8
2007 0 12.700.000 925.735 2
2006 0 11.919.720 1.311.007 5
2005 0 45.283.972 2.652.992 11
2004 0 55.974.059 2.324.408 9
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE76
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE17
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS13
KAROLINSKA INSTITUTE13
KATHOLIEKE UNIVERSITEIT LEUVEN12
COMMISSARIAT A L'ENERGIE ATOMIQUE10
KING'S COLLEGE LONDON10
UNIVERSITE DE GENEVE10
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE9
CHARITE UNIVERSITAETSMEDIZIN BERLIN8
INSTITUT PASTEUR8
UNIVERSITAETSKLINIKUM HEIDELBERG8
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS7
MEDICAL RESEARCH COUNCIL7
UNIVERSITY COLLEGE LONDON7
UNIVERSITY OF WALES CARDIFF7
DEPARTMENT OF HEALTH6
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK6
EUROPEAN MOLECULAR BIOLOGY LABORATORY6
FOLKHALSOMYNDIGHETEN6
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI6
MEDIZINISCHE HOCHSCHULE HANNOVER6
MEDIZINISCHE UNIVERSITAET WIEN6
UNIVERSITE DE LIEGE6
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM5
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER5
CORIS BIOCONCEPT SPRL5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
GOETEBORGS UNIVERSITET5
HEALTH PROTECTION AGENCY5
INSTITUTO DE SALUD CARLOS III5
PHILIPPS UNIVERSITAET MARBURG5
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON5
UNIVERSITAETSKLINIKUM FREIBURG5
UNIVERSITEIT MAASTRICHT5
UNIVERSITY OF GLASGOW5
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT4
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE4
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANIISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO4
ISTITUTO SUPERIORE DI SANITA4
LEIDEN UNIVERSITY MEDICAL CENTER4
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE4
REGION HOVEDSTADEN4
STICHTING KATHOLIEKE UNIVERSITEIT4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE HEBREW UNIVERSITY OF JERUSALEM4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITA DEGLI STUDI DI MILANO4
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA4
UNIVERSITAET LEIPZIG4
UNIVERSITAET ULM4
UNIVERSITAETSKLINIKUM AACHEN4
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI4
UNIVERSITEIT ANTWERPEN4
UNIVERSITY OF BIRMINGHAM4
UPPSALA UNIVERSITET4
VRIJE UNIVERSITEIT BRUSSEL4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ACADEMISCH ZIEKENHUIS LEIDEN3
AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL3
CELLARTIS AB3
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE3
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
DEBRA EUROPE3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT3
FUNDACAO OSWALDO CRUZ3
GENETHON3
HACETTEPE UNIVERSITESI3
HADASSAH MEDICAL ORGANIZATION3
HELLENIC PASTEUR INSTITUTE3
HOSPICES CIVILS DE LYON3
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDIZINISCHE UNIVERSITAET GRAZ3
MEDIZINISCHE UNIVERSITAT GRAZ3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA' E DELLA RICERCA3
MOSAIQUES DIAGNOSTICS3
PHILIPPSUNIVERSITAET MARBURG3
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY3
TECHNISCHE UNIVERSITAET DRESDEN3
TEL AVIV UNIVERSITY3
THE UNIVERSITY OF BRISTOL3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAET STUTTGART3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM BONN3
UNIVERSITAETSKLINIKUM FREIBURG FUER DIE MEDIZINISCHE FAKULTAET DER ALBERT LUDWIGS UNIVERSITAET3
UNIVERSITE CATHOLIQUE DE LOUVAIN3
UNIVERSITE D'AIX MARSEILLE3
UNIVERSITEIT UTRECHT3
Constancy:

Total number of partners:1400

Partner loyalty:
Frequent Partner: (> 2 projects): 559
Rare Partner: 841

Frequent / Rare Partner Ratio: 0.66

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES60
RTD HORIZONTAL TOPICS26
SOCIAL AND ECONOMIC CONCERNS12
INDUSTRY AND TECHNOLOGY1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAparticipant4.822.1979
2020-01-01Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility miniNOparticipant6.487.77010
2020-01-01Gene Therapy to restore lymphatic flow lymphedema TheraLymphparticipant8.064.94611
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bparticipant9.983.02914
2020-01-01Impact of exposome on the course of lung diseases REMEDIAparticipant11.134.61614
2020-01-01FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA FAIRparticipant10.162.90411
2020-01-01Brain injury in the premature born infant: stem cell regeneration research network PREMSTEMparticipant8.999.62015
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTparticipant3.429.2176
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-01-01Advancing European Research Infrastcuture on Highly Pathogenic Agents ERINHA-Advanceparticipant3.246.80511
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2019-01-01An integrative strategy of testing systems for identification of EDs related to metabolic disorders OBERONparticipant5.978.76312
2019-01-01Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics VHFMoDRADparticipant3.316.01313
2019-01-01Integrating Environment and Health Research: a Vision for the EU HERAparticipant3.097.32325
2018-01-01Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative R-LiNKparticipant7.702.53221
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54612
2017-01-01Crimean-Congo Haemorrhagic Fever Vaccine CCHFVaccineparticipant5.979.60714
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20956
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52243
2016-01-01Investigating the impact of meditation training on mental health and wellbeing in the ageing population MEDIT-AGEINGparticipant6.134.75611
2016-01-01European Research Infrastructure on Highly Pathogenic Agents 2 ERINHA2participant1.443.92716
2015-11-01Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases JPsustaiNDparticipant2.043.28416
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512
2015-05-01Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension ENSAT-HTparticipant7.607.33713
2015-05-01Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone FAIR-PARK-IIparticipant5.998.99415
2014-02-01Nanotherapeutics for antibiotic resistant emerging bacterial pathogens NAREBparticipant9.674.15815
2014-02-01Anti-Parasitic Drug Discovery in Epigenetics A-PARADDISEparticipant5.999.99116
2013-11-01Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders BRAINTRAINparticipant5.998.66110
2013-10-01"Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis" MYASTERIXcoordinator5.900.7205
2013-10-01"Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease" REPAIR-HDparticipant6.000.0009
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2013-09-01Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus POC-HCVparticipant5.991.4265
2013-07-01Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society NANODIODEparticipant1.899.84214
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013
2013-02-01Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility NANOATHEROparticipant9.833.34816
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-01-01SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING AGEDBRAINSYSBIOparticipant6.000.00014
2012-11-01Metagenomics in Cardiometabolic Diseases METACARDISparticipant11.999.99215
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-10-01Highlighting EU-funded Health research results via TV media and the internet HIGHLIGHTparticipant999.4906
2012-09-01Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems. EE-ASIparticipant5.983.8718
2012-09-01European Network of Knowledge Transfer in Health ENTENTEcoordinator1.999.9857
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Chips for Life C4Lparticipant2.876.3008
2012-01-01Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MYRparticipant2.999.49810
2011-12-01Innovative strategies to generate human hepatocytes for treatment of metabolic Liver diseases: Tools for personalized cell therapy InnovaLivparticipant5.884.1717
2011-03-01Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector GENEGRAFTparticipant4.961.65410
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2011-01-01HEPATIC MICROFLUIDIC BIOREACTOR HeMiBioparticipant4.700.00013
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXparticipant4.700.00015

overview shows latest 50 from 98 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSERM TRANSFERT

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum